Jazz Pharmaceuticals plc Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Jazz Pharmaceuticals plc (JAZZ) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 110.00 thousand shares for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-01.
Discontinued › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2022-03-01
- Jazz Pharmaceuticals plc share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2021 was 110.00K shares, a 86.63% decline from fiscal 2020.
- Jazz Pharmaceuticals plc share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2020 was 823.00K shares, a 51.33% decline from fiscal 2019.
- Jazz Pharmaceuticals plc share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2019 was 1.69M shares, a 16.70% increase from fiscal 2018.
- Jazz Pharmaceuticals plc share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2018 was 1.45M shares, a 3.35% increase from fiscal 2017.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|
| 2021-12-31 | 110.00K shares 10-K · filed 2022-03-01 |
| 2020-12-31 | 823.00K shares 10-K · filed 2021-02-23 |
| 2019-12-31 | 1.69M shares 10-K · filed 2020-02-25 |
| 2018-12-31 | 1.45M shares 10-K · filed 2019-02-26 |
| 2017-12-31 | 1.40M shares 10-K · filed 2018-02-27 |
| 2016-12-31 | 1.31M shares 10-K · filed 2017-02-28 |
| 2015-12-31 | 1.12M shares 10-K · filed 2016-02-23 |
| 2014-12-31 | 1.00M shares 10-K · filed 2015-02-24 |
| 2013-12-31 | 1.35M shares 10-K · filed 2014-02-25 |
| 2012-12-31 | 2.16M shares 10-K · filed 2013-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |